2m 2m 2m 2m 2m 2m 2m
ROCKWELL MEDICAL (RMTI)
NASDAQ
$0.69+$0.01 (+2.12%)
Price as of Jun 03, 2026 7:59 PM EDT- $29.3MMarket Cap
- -33.10%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ROCKWELL MEDICAL (RMTI)
$0.69+$0.01 (+2.12%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 69.3M -31.76% | 101.5M +21.38% | 83.6M +14.84% | 72.8M +17.57% | |
Cost of Revenue | 57.6M -31.48% | 84.0M +12.14% | 74.9M +8.98% | 68.7M +6.81% | |
Gross Profit | 11.7M -33.11% | 17.5M +100.87% | 8.7M +113.49% | 4.1M +268.47% | |
Sales and Marketing Expense | 2.4M -14.37% | 2.7M +29.36% | 2.1M +1.48% | 2.1M -63.47% | |
Research and Development Expense | 0 +100.00% | -19,000 -98.28% | -1.1M -64.51% | -3.1M -54.37% | |
Depreciation and Amortization Expense | 2.2M +0.55% | 2.2M +50.97% | 1.4M +150.69% | 576,000 -13.77% | |
Total Operating Expenses | 57.6M -31.48% | 84.0M +12.14% | 74.9M +8.98% | 68.7M +6.81% | |
Operating Profit | -4.7M -871.55% | 608,000 +109.12% | -6.7M -60.25% | -16.8M -44.69% | |
Interest Income | N/A N/A | N/A N/A | 211,000 +539.39% | 33,000 +50.00% | |
Interest Expense | N/A N/A | -1.0M -56.54% | -2.3M +18.85% | -1.9M -17.97% | |
Interest Income and Expense and Net | 0 +100.00% | -1.0M -52.15% | -2.1M +9.83% | -1.9M -18.61% | |
Total Nonoperating Income and Expense | -623,000 -42.74% | -1.1M -38.50% | -1.8M -6.85% | -1.9M -18.78% | |
Income before Taxes | -4.7M -871.55% | 608,000 +109.12% | -6.7M -60.25% | -16.8M -44.69% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -5.3M +1,007.08% | -480,000 -94.31% | -8.4M -54.82% | -18.7M -42.83% | |
Net Income from Continuing Operations Applicable to Common | -5.3M +1,007.08% | -480,000 -94.31% | -8.4M -54.82% | -18.7M -42.83% | |
Basic EPS and Net Income | -0.15 +400.00% | -0.03 -91.89% | -0.37 -80.42% | -1.89 +440.00% | |
Diluted EPS and Net Income | -0.15 +400.00% | -0.03 -91.89% | -0.37 -80.42% | -1.89 +440.00% | |
Basic Weighted Average Shares | 36.0M +15.83% | 31.1M +33.17% | 23.3M +136.38% | 9.9M -89.48% | |
Diluted Weighted Average Shares | 36.0M +15.83% | 31.1M +33.17% | 23.3M +136.38% | 9.9M -89.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.7M -31.61% | 15.7M +74.35% | 9.0M -11.08% | 10.1M -23.93% | |
Short-Term Investments | 14.3M +140.51% | 5.9M +204.30% | 2.0M -82.86% | 11.4M +24.37% | |
Cash and Cash Equivalents and Short-Term Investments | 25.0M +15.72% | 21.6M +97.55% | 10.9M -49.12% | 21.5M -4.22% | |
Total Current Assets | 38.2M +3.06% | 37.0M +28.71% | 28.8M -18.52% | 35.3M +0.06% | |
Accumulated Depreciation | 10.7M +3.07% | 10.4M +18.15% | 8.8M +15.30% | 7.6M +7.50% | |
Property and Plant and Equipment and Net | 4.6M -19.98% | 5.8M -9.64% | 6.4M +191.80% | 2.2M -11.75% | |
Total Long-Term Assets | 556,000 +5.30% | 528,000 +0.19% | 527,000 +0.76% | 523,000 -15.51% | |
Total Assets | 57.1M -3.48% | 59.2M +13.48% | 52.2M +11.88% | 46.6M -3.99% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 264,000 -1.49% | 268,000 N/A | 0 -100.00% | 1.6M -77.90% | |
Total Current Liabilities | 9.6M -32.01% | 14.1M -15.30% | 16.6M -5.96% | 17.7M -15.62% | |
Total Long-Term Debt | 8.8M +4.18% | 8.5M -0.76% | 8.5M +5.94% | 8.1M -40.85% | |
Total Long-Term Liabilities | 10.3M N/A | 0 -100.00% | 14,000 0.00% | 14,000 0.00% | |
Total Liabilities | 20.2M -24.26% | 26.6M -13.79% | 30.9M -5.06% | 32.5M -29.34% | |
Retained Earnings | -403.0M +1.34% | -397.7M +0.12% | -397.2M +2.17% | -388.8M +5.05% | |
Total Stockholders Equity | 37.0M +13.49% | 32.6M +53.05% | 21.3M +50.94% | 14.1M +456.45% | |
Total Shares Outstanding | 39.4M +15.70% | 34.1M +16.91% | 29.1M +139.49% | 12.2M -87.06% | |
Cash Flow | |||||
Cash from Operating Activities | -659,000 -115.68% | 4.2M +144.65% | -9.4M -45.95% | -17.4M -48.07% | |
Capital Expenditures | 542,000 -46.39% | 1.0M +255.99% | 284,000 +1.07% | 281,000 -46.17% | |
Cash from Investing Activities | -8.5M +75.59% | -4.9M +59.80% | -3.0M +27.09% | -2.4M -870.42% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 4.3M -42.13% | 7.3M -35.21% | 11.3M -31.81% | 16.6M +863.29% | |
Financials Ratio | |||||
Gross Margin | 16.89% -1.98% | 17.23% +65.49% | 10.41% +85.91% | 5.60% +243.30% | |
Operating Margin | -6.77% -1,230.56% | 0.60% +107.51% | -7.98% -65.39% | -23.05% -52.95% | |
Return on Assets | -9.13% +959.79% | -0.86% -94.95% | -17.08% -56.47% | -39.24% -24.15% | |
Return on Equity | -15.28% +757.41% | -1.78% -96.26% | -47.68% -78.76% | -224.49% +26.09% | |
Revenue Growth | -31.76% -248.53% | 21.38% +44.12% | 14.84% -15.54% | 17.57% +4,207.15% | |
Current Ratio | 3.98 +51.59% | 2.63 +51.96% | 1.73 -13.36% | 2.00 +18.58% | |
Cash Ratio | 1.12 +0.59% | 1.11 +105.87% | 0.54 -5.45% | 0.57 -9.85% | |
Debt-to-Equity Ratio | 0.25 -8.35% | 0.27 -33.12% | 0.40 -41.62% | 0.69 -91.71% | |
Debt-to-Assets Ratio | 0.16 +7.79% | 0.15 -9.78% | 0.16 -21.27% | 0.21 -51.94% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow